sales@nebiolab.com Email Your Inquiry
(203) 361 3780 Speak to Our Scientists
Agile Bioanalysis Services CRO
  • Expertise
    • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
    • Meso Scale Discovery Assay
    • Luminex Multiplex Assay
    • LI-COR Odyssey Assay
    • PK PD Analysis
    • Method Development, Validation, and Transfer
      • Method Validation
      • Method Development
      • Method Transfer
  • Services
    • All Services
    • Pharmacokinetics (PK) Study
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • ADME Studies
    • Toxicology (Tox) Study
      • Dose Formulation Analysis
    • ADA Assay Immunogenicity Testing
    • Biomarker Testing Services
      • Biomarker Assay List
    • Bioequivalence and Bioavailability Studies
    • Bioanalytical Assay
      • Biochemical Assay
      • Mechanism of Action (MOA) Studies
      • Cell-based Assays
      • Cytotoxicity Assay
  • Solutions
    • All Solutions
    • Bioanalysis
    • GLP Laboratory
    • Clinical CRO
      • Clinical Trial Sample Management and Storage
    • Preclinical CRO
    • Analytical Testing
      • Analytical Quantitation
    • Non-GLP Testing
      • Discovery and Research
      • Cosmetic Testing
  • About Us
    • About Us
    • Overview
    • Why Us?
    • Values
    • Leadership
    • Process
    • Quality and Compliance
    • Facility and Equipment
    • Therapeutic Areas
    • Partners
    • Careers
      • GLP Quality Assurance Manager, Bioanalytical Lab
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist – Pharmacokinetics (PK) Studies
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Learning Center
    • Blog
    • Case Study
    • News and Events
    • Testimonials
    • Contact Us
  • Request Quote
Agile Bioanalysis Services CRO Request Quote

Expertise

  • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
      • Meso Scale Discovery Assay
        • Luminex Multiplex Assay
          • LI-COR Odyssey Assay
            • PK PD Analysis
              • Method Development, Validation, and Transfer
                • Method Validation
                • Method Development
                • Method Transfer

              Services

              • All Services
                • Pharmacokinetics (PK) Study
                  • Drug Metabolism and Pharmacokinetics (DMPK)
                  • ADME Studies
                • Toxicology (Tox) Study
                  • Dose Formulation Analysis
                • ADA Assay Immunogenicity Testing
                  • Biomarker Testing Services
                    • Biomarker Assay List
                  • Bioequivalence and Bioavailability Studies
                    • Bioanalytical Assay
                      • Biochemical Assay
                      • Mechanism of Action (MOA) Studies
                      • Cell-based Assays
                      • Cytotoxicity Assay

                    Solutions

                    • All Solutions
                      • Bioanalysis
                        • GLP Laboratory
                          • Clinical CRO
                            • Clinical Trial Sample Management and Storage
                          • Preclinical CRO
                            • Analytical Testing
                              • Analytical Quantitation
                            • Non-GLP Testing
                              • Discovery and Research
                              • Cosmetic Testing

                            About Us

                            • About Us
                              • Overview
                                • Why Us?
                                  • Values
                                    • Leadership
                                      • Process
                                        • Quality and Compliance
                                          • Facility and Equipment
                                            • Therapeutic Areas
                                              • Partners
                                                • Careers
                                                  • GLP Quality Assurance Manager, Bioanalytical Lab
                                                  • Sr. Scientist, ELISA Immunoassay Bioanalysis
                                                  • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
                                                  • Associate Scientist, Central Laboratory Services
                                                  • Sr. Scientist - Pharmacokinetics (PK) Studies
                                                  • Content Manager, Scientific and Regulatory Writing

                                                Resources

                                                • Learning Center
                                                  • Blog
                                                    • Case Study
                                                      • News and Events
                                                        • Testimonials
                                                          • Contact Us

                                                            Request Quote

                                                              Contact Us

                                                              NorthEast BioLab Logo Agile Bioanalysis Services CRO
                                                              Request Quote Contact Us
                                                              • Home
                                                              • Pharmacokinetics (PK) Study Assay Services Lab CRO

                                                              Reliable Pharmacokinetic (PK) Assay Lab Services CRO Trusted By Biotech Pioneers Over 20+ Years!

                                                              • FDA Audited PK, ADA Assay Services To De-Risk Your Therapeutics Portfolio
                                                              • High-Value, Pharmacokinetic (PK) Study With Your Prodrug Or Metabolites
                                                              • SAD MAD Clinical Pharmacokinetics Services At Industry-Leading Turnaround
                                                              • GLP PK Bioanalysis Fully Validated On LC-MS/MS, ELISA, MSD, Or QPCR
                                                              Good Laboratory Practice for Nonclinical Laboratory StudiesFood and Drug Administration (FDA)

                                                              Provide Your Bioanalysis Study Details

                                                              We Will Contact You Within 1 Business Day

                                                              Click Below For Answers To Your Pharmacokinetics (PK) Study Questions -
                                                              • What is a Pharmacokinetic (PK) Study?
                                                                What is a Pharmacokinetic (PK)
                                                                Study?
                                                              • When is PK Analysis performed during Drug Development?
                                                                When is PK Analysis performed during Drug Development?
                                                              • Which PK Assay and PK Analysis Services do we Offer?
                                                                Which PK Assay and PK Analysis Services do we Offer?
                                                              • Why Choose us for your Pharmacokinetics (PK) Study?
                                                                Why Choose us for your Pharmacokinetics (PK) Study?

                                                              PK Assay Services CRO Trusted By Biotech Over 20+ Years!

                                                              • PK Assay Analysis Services At Industry-Leading Turnaround
                                                              • Tailor-Made, High-Value PK Study Assay Services For Biotech
                                                              • Full-Service PK Testing From GLP Preclinical Method Development To Clinical Trial Sample Analysis
                                                              • PK Bioanalysis Services For Small Molecules, Peptides, mAbs, etc
                                                              SPEAK TO OUR SCIENTISTS

                                                              What Is A Pharmacokinetic (PK) Study?

                                                              Pharmacokinetics (PK) Study: Drug Concentration vs. Time in the Body

                                                              A pharmacokinetic study provides the basis for determining drug exposures in the body over time. PK parameters are used in the evaluation of the absorption, distribution, metabolism, and excretion (ADME) processes of drugs.

                                                              Absorption

                                                              Absorption, the first topic of PK studies, is the initial process by which drugs enter the blood circulation following dosing. Drug substances in PK lab testing can be administered to the body through several routes such as oral, nasal, dermal, or parenteral. Absorption at the gastrointestinal tract, one of the most common drug absorption sites, is affected by several factors including physicochemical parameters of the drug, gastrointestinal motility, drug concentration, and ionization state at the site of absorption.

                                                              Distribution

                                                              Distribution is a reversible drug transfer within the body from one location to another. The distribution of a drug can be influenced by several factors such as lipid-solubility, concentration in plasma and various tissues, and protein binding of drugs in plasma and tissues. PK studies assess whether compounds can distribute throughout the body readily or are confined to the bloodstream once absorbed.

                                                              Metabolism

                                                              Metabolism, an essential topic of PK analysis, is the process by which a drug is converted to another chemical entity (metabolite). Metabolism happens primarily in the liver and is classified into two broad categories: Oxidative metabolism includes hydrolysis, oxidation, and reduction reactions driven mainly by the cytochrome P450s, monooxygenase systems, and alcohol dehydrogenases. The typical chemical reactions involved in oxidative metabolism include aromatic hydroxylation, aliphatic hydroxylation, oxidative N dealkylation, oxidative O-dealkylation, S-oxidation, reduction, methylation, and hydrolysis. Most often, these reactions increase compound polarity to make a drug more soluble, facilitating elimination through the kidneys. In conjugative metabolism, conjugation occurs by glucuronidation, sulfation, amino acid conjugation, acetylation, or glutathione conjugation to aid elimination. Enzymes involved in conjugation include UDP glucoronyl transferases, aryl sulfatases, N-acetyl transferases, and glutathione S-transferases. Conjugation can serve to inactivate a compound or make it more readily eliminated by urinary or biliary excretion. Several factors influence a drug’s rate of metabolism, including the route of administration, dose, genetics, disease state, and metabolic activity.

                                                              Excretion

                                                              Eliminating the drug and other toxic substances from the body, the last topic of the PK study, is known as the process of excretion. Most drugs in the body are eliminated through the urine. Excretion also depends on the solubility of the drug in water. More soluble drugs are excreted faster in the urine. If the excretion is incomplete, the accumulation of compounds in the body can lead to adverse events. Pharmacokinetics study testing should incorporate sufficient sampling times during compound elimination for appropriate assessments of parameters such as elimination half-life and clearance.

                                                              What Our Sponsors Have to Say?

                                                              VP, Bioanalytical Development

                                                              NorthEast BioLab is by far the most responsive and thorough bioanalysis lab services CRO.

                                                              VP, Biomarker Development 

                                                              We partnered on several programs and found NorthEast BioLab responsive, collaborative, and reliable.

                                                              Executive Director, Pharmacokinetics

                                                              We trust NorthEast BioLab to design and execute the most streamlined and impactful bioanalytical projects.

                                                              President & CSO, Biotech

                                                              We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.

                                                              Sr. Associate Director, Clinical Trials

                                                              We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.

                                                              Co-Founder, Biotech & University PI

                                                              NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.

                                                              VP, PK PD Analysis

                                                              NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.

                                                              Head, Bioanalytical Development

                                                              NorthEast BioLab truly goes that extra mile, and we hope to continue enjoying seminal interactions with them.

                                                              Sr.Director, Bioanalytical Development & QC

                                                              NorthEast BioLab presents a science-based, hands-on, no-frills approach on the latest bioanalytical platforms.

                                                              SVP Quality & Compliance, Biotech

                                                              We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.

                                                              Director, PK

                                                              We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.

                                                              VP, Head of Clinical Operations

                                                              Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.

                                                              Executive Director, Drug Research

                                                              NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.

                                                              Director, Bioequivalence Testing

                                                              Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.

                                                              Head, PK

                                                              This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with top quality and reporting standard with incredible responsiveness.

                                                              VP, Development Operations

                                                              As a small company, our vendors are key members of our project teams. The scientists at NorthEast BioLab are technical experts, who produce high-quality data, on-time, and on-budget.

                                                              Ready To Take The First Step, Today?

                                                              Explore Our Pharmacokinetics (PK) Study Assay Services Lab CRO!
                                                              SPEAK TO OUR SCIENTISTS

                                                              When is PK Analysis Performed During Drug Development?

                                                              PK Analysis: From Drug Discovery and Preclinical to Clinical Phases

                                                              PK analysis is performed throughout the drug research and development process, starting from early discovery to the last Phase of drug development. The primary purpose of preclinical pharmacokinetic studies is to evaluate the characteristics of potential drugs to predict exposures and determine dose levels and frequencies for testing new chemical entities in preclinical disease efficacy models. PK studies in multiple species can be used to predict human pharmacokinetics and estimate the dose required for clinical efficacy and potential manufacturing costs for the intended drug product after achieving therapeutic proof-of-concept and honing structure-activity-relationships (SAR) to determine lead molecules. Pharmacokinetic (PK) Assays during the preclinical phase help determine bioavailability, the volume of distribution, half-life, and clearance. These PK studies help evaluate if the drug has adequate success potential or needs to be modified to improve its pharmacokinetic parameters. Pharmacokinetic (PK) study results from the preclinical stage help design IND enabling Tox studies in animals, and drugs can be advanced farther into clinical development based on these preclinical results. PK bioanalysis meeting the requirements for first in human (FIH) dosing initially undergo single ascending dose (SAD) clinical trials to assess the safety and clinical pharmacokinetics, followed by later multiple ascending dose (MAD) clinical trials to assess steady-state exposures and to correlate with drug pharmacology.

                                                              Introduction To Pharmacokinetics

                                                              Introduction to Pharmacokinetics

                                                              Pharmacokinetics (PK) is the analysis and description of the disposition of a drug in the body, encompassing development of the mathematical description of all dispositional processes in the body, defined as ADME – absorption, distribution, metabolism, and elimination…

                                                              Read More At Our Learning Center

                                                              Which PK Assay and PK Analysis Services Do We Offer?

                                                              PK Assay and PK Analysis Services by NorthEast BioLab

                                                              We offer a wide range of Pharmacokinetic (PK) Assays beginning from the early discovery phase when a potential drug compound is administered to rodents for understanding ADME properties. Once a compound is found suitable for further development, we also provide Pharmacokinetic (PK) testing services for dose range finding studies followed by IND enabling Toxicology (Tox) studies in rodent and non-rodent animals. PK studies in animals are critical for safely advancing the drug into clinical development. We provide pharmacokinetics services during clinical trials by developing and validating bioanalytical methods in the human biological matrices post the FDA approval of your IND application.

                                                              Once your PK bioanalysis is completed, we can complete your Pharmacokinetics (PK) study by calculating relevant parameters for your compound. Additionally, we are glad to assist you with protocol and study design, study execution, and interpretation of your PK data, and/or provide guidance on compound selection, dose levels, collection intervals for preclinical efficacy testing. We maintain fully validated Phoenix WinNonlin software at our facility for non-compartmental analyses (NCA) and PK modeling. Our team can generate formally audited bioanalytical reports for all your regulated studies from early discovery through clinical development.

                                                              PK Analysis

                                                              Registered And Inspected By Various Regulatory Agencies

                                                              Why Choose Us For Your Pharmacokinetics (PK) Study?

                                                              Accurate Pharmacokinetics (PK) Study to Assess your Drug’s Proper Exposure and Therapeutic Potential

                                                              Pharmacokinetics studies for ADME and toxicokinetic analysis demand both in-depth expertise and nimble execution. NorthEast BioLab is the right partner to assist you in bringing new, effective drugs to the market given the critical and detail-orientated nature of these PK studies in pharmaceutical drug development.

                                                              Our team of veteran scientists can help discern your top drug compound based on our 20+ years of experience in method development, validation, transfer for PK bioanalysis and related assay. Together, we can develop robust bioanalytical methods to support your PK studies for the analysis of drugs and metabolites in biological fluids followed by the calculation of PK parameters by non-compartmental analysis (NCA). We promise a high quality and take full responsibility for all your projects, including compliance with various regulations mandated by authorities and agencies such as FDA and ICH.

                                                              You can de-risk your drug portfolio right away by leveraging our FDA audited Pharmacokinetics (PK) Study Assay, Testing, And Sample Analysis Services offered to premier biotech/pharma since the early 2000s. We regularly conduct SAD MAD Pharmacokinetics (PK) Studies to determine drug behavior in the body and facilitate critical decision-making on dosage and safety. Our scientists generate and model your GLP PK bioanalysis data using fully validated assay and WinNonlin software. Speak to our Scientists to get started on your first PK Assay with us.

                                                              Questions On Our Pharmacokinetics (PK) Study Assay Lab CRO Services?

                                                              Our Experienced Scientists Are Ready To Help You, Today!
                                                              SPEAK TO OUR SCIENTISTS

                                                              Related FAQs

                                                              Answers to additional Pharmacokinetics (PK) Study questions popular among our potential clients.

                                                              What does PK stand for in clinical trials?

                                                              We perform PK studies in clinical trials to examine the absorption, distribution, metabolism, and excretion of a drug. These studies are useful for determining the appropriate dose range for safety and efficacy in subsequent trials. Pharmacokinetic (PK) testing involves a quantitative analysis of the time course of a drug in the body. PK testing in clinical trials often assesses single ascending doses (SAD studies) to investigate dosage proportionality and multiple ascending doses (MAD studies) to correlate the PK effect changes with repeated dosage. SAD and MAD PK studies in clinical trials provide information regarding metabolic alterations and the achievement of steady-state exposures during chronic therapies. Other clinical PK studies include bioavailability and bioequivalence studies, assessment of drug-drug interaction (DDI) potential, and drug penetration studies depending on the therapeutic target.

                                                              What is the main purpose of PK testing?

                                                              In early drug discovery, we often perform PK testing to determine whether new chemical entities (NCEs) have adequate exposures for in-vivo efficacy models in mice. Even before dosing in the animals, we typically perform in-vitro pharmacokinetic services to filter out compounds with high metabolic rates or weak absorption potential. During preclinical development, pharmacokinetic testing in additional species is generally performed in one rodent and one non-rodent species to prepare for toxicology and toxicokinetics studies. Additional PK services include allometry or other scaling models to predict clinical PK from the preclinical data ahead of the clinical trials. Early clinical PK studies are often performed at sub efficacious dosage with slow dose escalation to maintain safety and determine the clinical PK parameters while ramping towards therapeutic doses. For reformulations or generics of approved compounds, we perform PK testing to demonstrate bioequivalence. During all drug development phases, PK lab test results may be used to assess dose proportionality, steady-state exposure levels, bioavailability, and the general ADME properties of the test compounds in the various test species.

                                                              How do you perform a pharmacokinetic study?

                                                              Pharmacokinetic (PK) study design follows some basic general principals even as it varies based on the chemical structures of the tested compounds and the intended therapeutic targets. Initially, we dissolve the test compound in an appropriate dosing vehicle. Then, the test species is dosed with the vehicle and blood samples are collected over a pre-specified period for drug concentration analysis. Afterward, we plot the blood draw time vs. concentration curves and calculate the PK parameters such as the area under the curve, maximum concentration, clearance, distribution volume, elimination half-life, etc. We select the species and strains for pharmacokinetics studies in animals to meet our objective towards proving compound efficacy and safety with the ultimate goal of reaching the clinic and marketplace. During drug discovery, PK studies in mice and rats are often performed in tandem with pharmacodynamic studies to achieve in-vivo proof of concept against a disease target. Late phase discovery and development PK studies are performed in multiple species to support preclinical toxicology and regulatory submissions.

                                                              What is the importance of pharmacokinetics analysis in drug development?

                                                              Pharmacokinetic analysis provides direct information about the fate of a test compound in the body. Pharmacokinetics research focuses on the relationship between the dosing regimen and the body’s exposure to the drug. Typically, we generate PK data through non-compartmental analysis. Non-compartmental PK parameters include area under the curve (AUC), maximum exposure (Cmax), clearance (CL or CL/F), distribution volume (Vd or Vd/F), elimination half-life (t½), etc. These parameters provide crucial information about any drug’s absorption and elimination rates, as well as the potential to distribute to tissues throughout the body. Pharmacokinetics in drug development from multiple species can be used to predict dosing levels and regimens for efficacy in animal models of disease, for predictions of doses required for preclinical toxicology studies, and to scale predicted clinical PK parameters and estimate initial clinical doses.

                                                              What are the four major components of pharmacokinetics study?

                                                              Pharmacokinetic assays provide a quantitative description of what a body does to a drug. The four major components of the pharmacokinetics process are absorption, distribution, metabolism, and excretion commonly referred to as ADME. Absorption is the process of getting the drug from the site of delivery into the systemic circulation. For example, orally administered compounds must be soluble in the gut environment, then permeate the gastrointestinal tract and pass through the portal vein and the liver (known as the first pass) before reaching central circulation. Distribution describes the drug’s ability to enter and leave central circulation to reach tissues and organs throughout the body. Metabolism and excretion are the processes of eliminating drugs and xenobiotics from the body via metabolic processes or direct biliary or renal excretion of unchanged drug.

                                                              What is the difference between pharmacokinetics and pharmacodynamics?

                                                              Pharmacodynamics describes what the drug does to the body, and pharmacokinetics describes what the body does to the drug. Pharmacokinetics (PK) and pharmacodynamics (PD) are both components of in-vivo pharmacology. Pharmacokinetics evaluates absorption, distribution, metabolism, and excretion of drugs by the determination of systemic exposure over time. Pharmacodynamics studies the relationship between drug concentration at the site of action (receptor) and the observed pharmacological response. PK describes drug exposure, and PD describes drug effects. PK PD analysis provides the relationship between the drug’s in-vivo exposure and efficacy. PK PD studies in multiple species during drug discovery and development are often useful for predictions of initial dosing levels and regimens for safety and efficacy in the clinic.

                                                              What are pharmacokinetic (PK) parameters?

                                                              In-vivo PK drug assessments are critical in drug discovery, development, and clinical testing. Non-compartmental pharmacokinetic (PK) drug parameters vary depending on study design, but typically include volume of distribution (Vd) and total plasma clearance (CL) following IV doses, time to maximum concentration (Tmax), maximum observed concentration (Cmax), area under plasma concentration vs. time curve (AUC), elimination half-life (t1/2) for all dose routes, and bioavailability (F%) where extravascular and IV routes have been tested. As appropriate, our team of experienced scientists at NorthEast BioLab can aid you in study and protocol design, study monitoring, sample bioanalysis, pharmacokinetics parameter calculation using validated Phoenix WinNonlin software, and result interpretation during all project phases.

                                                              Explore More Services

                                                              • Pharmacokinetics (PK) Study Pharmacokinetics (PK)
                                                                Study
                                                              • Toxicology (Tox) Study Toxicology (Tox)
                                                                Study
                                                              • Immunogenicity Testing Immunogenicity
                                                                Testing
                                                              • Biomaker Testing Services Biomaker Testing
                                                                Services
                                                              • Bioequivalence and Bioavailability Studies Bioequivalence and Bioavailability Studies
                                                              • Bioanalytical Assay Bioanalytical
                                                                Assay

                                                              Expertise

                                                              • Liquid Chromatography Mass Spectrometry
                                                              • ELISA Method
                                                              • Meso Scale Discovery Assay
                                                              • Luminex Multiplex Assay
                                                              • LI-COR Odyssey Assay
                                                              • PK PD Analysis
                                                              • Method Development Validation and Transfer

                                                              Services

                                                              • Pharmacokinetics (PK) Study
                                                              • Toxicology (Tox) Study
                                                              • ADA Assay Immunogenicity Testing
                                                              • Biomarker Testing Services
                                                              • Bioequivalence and Bioavailability Studies
                                                              • Bioanalytical Assay

                                                              Solutions

                                                              • Bioanalysis
                                                              • GLP Laboratory
                                                              • Clinical CRO
                                                              • Preclinical CRO
                                                              • Analytical Testing
                                                              • Non-GLP Testing

                                                              About Us

                                                              • Overview
                                                              • Why Us?
                                                              • Values
                                                              • Leadership
                                                              • Process
                                                              • Quality and Compliance
                                                              • Facility and Equipment
                                                              • Therapeutic Areas
                                                              • Partners
                                                              • Careers

                                                              Resources

                                                              • Learning Center
                                                              • Blog
                                                              • Case Study
                                                              • News and Events
                                                              • Testimonials
                                                              • Contact Us
                                                              NorthEast BioLab Logo

                                                              35 Worth Ave, Hamden, CT 06518

                                                              sales@nebiolab.com
                                                              (203) 361 3780

                                                              Consult with a Scientist Now

                                                              We Will Contact You Within 1 Business Day

                                                              • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                              • Food and Drug Administration (FDA)
                                                              • United States Drug Enforcement Administration
                                                              • Connecticut State Department of Consumer Protection
                                                              • Privacy Policy
                                                              • Terms of Use
                                                              • Sitemap
                                                              © 2019 - 2025, NorthEast BioAnalytical Laboratories LLC. All rights reserved.

                                                              How Can We Help?

                                                              I agree to receive emails, calls, and messages, etc from NorthEast BioLab.

                                                              Before you go! Get
                                                              your FREE Download:

                                                              Top 7 Hidden Pitfalls to your Bioanalytical Milestones

                                                              Step by step guide on how to accelerate your drug approval

                                                              • Addressing Main Constraints
                                                              • Research Best Practices
                                                              • The Economic Advantage
                                                              • Critical Decision Marketing Mode Easy
                                                              • Legal Documentation Checklist
                                                              We won’t share your email, ever, See our privacy policy

                                                              No thanks, I don’t need to improve my drug approval process